E. Bertherat, Weekly Epidemiologic Reports: WHO, pp.289-92, 2019.

V. A. Feodorova and V. L. Motin, Vaccines against bacterial biothreat pathogens, Research SignPost, pp.175-233, 2011.

, DynPort Vaccine Company. Recombinant Plague Vaccine rF1V in Healthy Volunteers, Clinical Trials.gov: NIH. U.S. National Library of Medicine, 2011.

J. Province and C. , Immunogenicity and Safety of Subunit Plague Vaccine, Clinical Trials.gov: NIH. U.S. National Library of Medicine, 2015.

N. I. Mikshis and V. V. Kutyrev, Current state of the problem of vaccine development for specific prophylaxis of plague, Problems Particul Dangerous Infect (Russian), vol.1, pp.50-63, 2019.

A. Derbise, Y. Hanada, M. Khalife, E. Carniel, and C. E. Demeure, Complete protection against pneumonic and bubonic plague after a single oral vaccination, PLoS Negl Trop Dis, vol.9, p.4162, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02067827

J. Holmgren and A. M. Svennerholm, Vaccines against mucosal infections, Curr Opin Immunol, vol.24, pp.343-53, 2012.

M. M. Levine, Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine, BMC Biol, vol.8, p.129, 2010.

J. Frey, Biological safety concepts of genetically modified live bacterial vaccines, Vaccine, vol.25, pp.5598-605, 2007.

P. Minor, Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication, Vaccine, vol.27, pp.2649-52, 2009.

T. S. Kupper and R. C. Fuhlbrigge, Immune surveillance in the skin: mechanisms and clinical consequences, Nat Rev Immunol, vol.4, pp.211-233, 2004.

A. Derbise, C. Marín, A. , A. P. Blisnick, T. Huerre et al., An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague, PLoS NTD, vol.6, p.1528, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01104077

R. M. Olson and D. M. Anderson, Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model, PLoS ONE, vol.14, p.217440, 2019.

D. S. Southam, M. Dolovich, P. M. O'byrne, and M. D. Inman, Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia, Am J Physiol Lung Cell Mol Physiol, vol.282, pp.833-842, 2002.

, Groups of mice were injected sc with 10 7 CFU VTnF1 and were sacrificed at predetermined times. Organs and feces were collected and homogenized for bacteria load determination. Individual results from 7 mice per group are shown for skin (2 cm 2 around the site of injection), DLN from both sides, the whole spleen and 2-3 fecal pellets. The median is shown as a red horizontal bar, vivo dissemination of sc-injected VTnF1

C. E. Demeure, A. Derbise, C. Guillas, C. Gerke, S. Cauchemez et al., Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine, Vaccine, vol.37, pp.123-132, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02067807

Z. Zhao, Y. Xue, B. Wu, X. Tang, R. Hu et al., Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica, Infect Immun, vol.76, pp.2157-63, 2008.

S. W. Kashem, M. Haniffa, and D. H. Kaplan, Antigen-Presenting Cells in the Skin, Annu Rev Immunol, vol.35, pp.469-99, 2017.

V. Iannelli, Which Vaccines can be Given SQ? In: Vaxopedia, editor, 2019.

A. A. Lindberg, The history of live bacterial vaccines, Dev Biol Stand, vol.84, pp.211-220, 1995.

H. S. Warren, C. Fitting, E. Hoff, M. Adib-conquy, L. Beasley-topliffe et al., Resilience to bacterial infection: difference between species could be due to proteins in serum, J Infect Dis, vol.201, pp.223-255, 2010.

O. Rossi, I. Pesce, C. Giannelli, S. Aprea, M. Caboni et al., Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants, J Biol Chem, vol.289, pp.24922-24957, 2014.

K. Kabashima, T. Honda, F. Ginhoux, and G. Egawa, The immunological anatomy of the skin, Nat Rev Immunol, vol.19, pp.19-30, 2019.

J. J. Quereda, M. A. Nahori, J. Meza-torres, M. Sachse, T. et al., Listeriolysin S Is a Streptolysin S-Like Virulence Factor That Targets Exclusively Prokaryotic Cells In Vivo, MBio, vol.8, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01574988